Golden Lotus Labs · ProxiGene™

Stop guessing.
Start sequencing.

Two patients on the same GLP-1 or peptide protocol can respond in opposite directions — because their genetics, not your dosing chart, decide how they metabolize it. ProxiGene reads 400+ validated biomarkers from a saliva sample and hands your practice a protocol built on one patient’s actual biology.

See what it measures

For licensed clinicians, med spas & wellness practices. Non-invasive · CLIA-certified lab · 3-week turnaround.

Genetic Risk MatrixSample panel
Methylation (MTHFR)
High
Inflammatory response
Medium
Peptide receptor sensitivity
High
Telomerase function
Low
Glucose regulation
Medium
Neuroinflammation
Low

The Problem

Population-average protocols are costing you outcomes — and patients.

Every clinic dosing peptides or GLP-1s today is running on averages: the same starting dose, the same titration schedule, the same supplement stack for every patient who walks in. When a patient plateaus or reacts poorly, the assumption is compliance. Often, it’s genetics.

Standard Protocol

  • One dosing schedule for every patient
  • Adjustments made by trial and error
  • Non-responders assumed non-compliant
  • Supplement stack is generic, not personal
  • No visibility into metabolism variants

ProxiGene-Informed Protocol

  • +Dosing informed by receptor sensitivity data
  • +Risk flagged before the first prescription
  • +Non-response explained by genetic variant
  • +Peptide & supplement guidance is patient-specific
  • +Follow-up labs targeted to real risk areas

What It Measures

400+ SNPs, organized into six clinical categories

01

Cognitive Degeneration

Memory pathways, neuroinflammation markers, and long-term cognitive decline risk.

02

Longevity

Inflammatory response, telomerase function, and cellular repair capacity.

03

Psychological Resilience

Neurotransmitter pathways tied to brain fog, anxiety, and stress response.

04

Micronutrient Metabolism

B9/B12 deficiency risk and methylation efficiency.

05

Metabolism & Energy

Cholesterol, triglycerides, and blood glucose regulation variants.

06

Food Sensitivity

Lactose intolerance and gluten sensitivity markers.

The Report

One report, five things your protocol can act on immediately

Delivered within three weeks of sample collection — built for the exam room, not a research paper.

01

Genetic Risk Matrix

Color-coded High / Medium / Low snapshot across 15 core biomarkers — readable in one glance before an appointment.

02

Gene & SNP Detail

rsID-level data with allele impacts, for clinicians who want to see the underlying variant.

03

Peptide & Supplement Guidance

Physician-curated protocol recommendations mapped to each patient's findings.

04

Nutrition & Lifestyle Insights

Evidence-based recommendations tied directly to the genetic findings, not generic advice.

05

Follow-Up Lab Suggestions

Confirmatory and monitoring labs targeted to the risk areas the panel surfaced.

400+

Validated SNPs analyzed per panel

3 wks

Sample-to-report turnaround

CLIA

Certified lab partner analysis

FDA

Registered, cGMP-certified parent org

Request a Demo

See ProxiGene on a real patient profile

A 20-minute walkthrough of the panel, a sample report, and how practices are positioning ProxiGene with patients already on peptide or GLP-1 protocols.

ProxiGene™ provides genetic insights to inform protocol development. It is not a diagnostic tool and does not diagnose, treat, or prevent any medical condition.